BlackRock Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-48,055
| Closed | -$431K | – | 3066 |
|
|
2016
Q3 | $431K | Sell |
48,055
-5,518
| -10% | -$39.2K | ﹤0.01% | 2358 |
|
|
2016
Q2 | $288K | Sell |
53,573
-346
| -0.6% | -$1.77K | ﹤0.01% | 2456 |
|
|
2016
Q1 | $248K | Sell |
53,919
-12,914
| -19% | -$51.9K | ﹤0.01% | 2503 |
|
|
2015
Q4 | $347K | Sell |
66,833
-461
| -0.7% | -$2.67K | ﹤0.01% | 2346 |
|
|
2015
Q3 | $408K | Buy |
67,294
+26,964
| +67% | +$330K | ﹤0.01% | 2279 |
|
|
2015
Q2 | $637K | Buy |
40,330
+25,658
| +175% | +$312K | ﹤0.01% | 2173 |
|
|
2015
Q1 | $160K | Buy |
14,672
+1,253
| +9% | +$12.8K | ﹤0.01% | 2558 |
|
|
2014
Q4 | $141K | Buy |
13,419
+4,600
| +52% | +$44.9K | ﹤0.01% | 2596 |
|
|
2014
Q3 | $85K | Sell |
8,819
-230
| -3% | -$2.35K | ﹤0.01% | 2610 |
|
|
2014
Q2 | $105K | Sell |
9,049
-10,183
| -53% | -$92.7K | ﹤0.01% | 2590 |
|
|
2014
Q1 | $192K | Buy |
19,232
+6,339
| +49% | +$91.5K | ﹤0.01% | 2478 |
|
|
2013
Q4 | $168K | Buy |
12,893
+3,083
| +31% | +$42.5K | ﹤0.01% | 2443 |
|
|
2013
Q3 | $146K | Buy |
9,810
+8,303
| +551% | +$99.5K | ﹤0.01% | 2547 |
|
|
2013
Q2 | $14K | Buy |
+1,507
| New | +$10.2K | ﹤0.01% | 2543 |
|
BlackRock Group's RPTP Position: Q4 2016 in Review
BlackRock Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 48,055 shares — an estimated $431K sold.
BlackRock Group first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $637K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- BlackRock Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- BlackRock Group sold 48,055 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $431K.
- BlackRock Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- BlackRock Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $637K in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.